forest schroders isf global multiasset income fund
Schroders has unveiled its new go-anywhere Global Multi-Asset Income Fund for manager Aymeric Forest.
Schroders has unveiled its new go-anywhere Global Multi-Asset Income Fund for manager Aymeric Forest.
Invesco Perpetual is planning the launch of its own multi-manager business in the run-up to RDR.
By the end of Q2, MAM Funds is expected to launch a global multi-asset income proposition for Martin Gray and James Sullivan.
Advisers looking to outsource investment decisions to a multi-manager fund in the lead up to RDR should choose carefully, as very few have managed to perform consistently since 2008.
APCIMS has come a long way in the past year, so why for some does it still represent the industrys stuffy stock broking past rather than its modern multi-asset future?
Investec Asset Management is to launch two multi-asset managed solutions funds as part of a realignment of its product range ahead of RDR.
The IMA stats for January show retail investors want their money working for them but are not certain enough about their own views to invest outside safety-first assets.
Invesco Perpetual has become the latest fund house to announce the launch of a new multi-asset proposition, as the trend of readying ranges to appeal to outsourcing advisers picks up pace.
With the advent of RDR it is expected IFAs will increasingly outsource investment decisions presenting an opportunity for discretionary fund managers (DFMs) to offer their investment services. But fund houses are also making moves to appeal to outsourcing IFAS, through expanding their multi-asset propositions. Is there room for both or will one party’s success lead…
Heartwood Investment Management has expanded its multi-asset fund range with the addition of a defensive proposition.
Aviva Investors has announced the launch of two new multi-asset funds, adding to its existing range of three amid a move to rebrand them.
Pioneer Investments has launched a mirror of its US-domiciled multi-asset real return fund as a Sicav.